Duarte Nathalia Lopez, Bueno Ana Paula Silva, Sanches Bárbara Sarni, Ramos Gabriella Alves, Santos Julia Maria Bispo Dos, Silva Henrique Floriano Hess E, Pondé Janaina de Oliveira, Sá José Gilberto de, Rossi Priscila Mazucanti, Horn Patricia Regina Cavalcanti Barbosa, Sztajnbok Denise Cardoso das Neves, Rubini Norma de Paula Motta, da Costa Elaine Sobral, Milito Cristiane Bedran, de Abreu Thalita Fernandes, Land Marcelo Gerardin Poirot
Faculty of Medicine (FM), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.
Internal Medicine Postgraduate Program, Faculty of Medicine (FM), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.
Cancers (Basel). 2023 Apr 14;15(8):2292. doi: 10.3390/cancers15082292.
Lymphomas related to HIV are generally aggressive and have a poor prognosis, despite the use of combined antiretroviral therapy (cART) and effective chemotherapy treatment. To determine survival and prognostic factors in children and adolescents living with HIV (CLWH) in Rio de Janeiro (RJ), Brazil, who developed lymphomas, we performed a retrospective and observational study of vertically infected CLWH aged from 0 to 20 incomplete years during1995 to 2018 at five reference centers for cancer and HIV/AIDS treatment. Of the 25 lymphomas, 19 were AIDS-defining malignancies (ADM) and 6 were non-AIDS-defining malignancies (NADM). The 5-year overall survival (OS) and 5-year event-free survival (EFS) probabilities were both 32.00% (95% CI = 13.72-50.23%), and the 5-year disease-free survival (DFS) probability was 53.30% (95% CI = 28.02-78.58%). In the multivariate Cox regression analysis, performance status 4 (PS 4) was considered a poor prognostic factor for OS (HR 4.85, 95% CI = 1.81-12.97, = 0.002) and EFS (HR 4.95, 95% CI = 1.84-13.34, = 0.002). For the DFS, higher CD4+ T-cell counts were considered a better prognostic factor (HR 0.86, 95% CI = 0.76-0.97, = 0.017) in the multivariate Cox regression analysis. This study demonstrates, for the first time, survival and prognostic factors for CLWH who developed lymphomas in RJ, Brazil.
尽管采用了联合抗逆转录病毒疗法(cART)和有效的化疗,但与HIV相关的淋巴瘤通常具有侵袭性且预后较差。为了确定巴西里约热内卢(RJ)感染HIV的儿童和青少年(CLWH)发生淋巴瘤后的生存情况和预后因素,我们对1995年至2018年期间在五个癌症和HIV/AIDS治疗参考中心的0至20岁未完成整岁的垂直感染CLWH进行了一项回顾性观察研究。在这25例淋巴瘤中,19例为定义AIDS的恶性肿瘤(ADM),6例为非定义AIDS的恶性肿瘤(NADM)。5年总生存(OS)率和5年无事件生存(EFS)率均为32.00%(95%CI = 13.72 - 50.23%),5年无病生存(DFS)率为53.30%(95%CI = 28.02 - 78.58%)。在多变量Cox回归分析中,体能状态4(PS 4)被认为是OS(HR 4.85,95%CI = 1.81 - 12.97,P = 0.002)和EFS(HR 4.95,95%CI = 1.84 - 13.34,P = 0.002)的不良预后因素。对于DFS,在多变量Cox回归分析中,较高的CD4 + T细胞计数被认为是较好的预后因素(HR 0.86,95%CI = 0.76 - 0.97,P = 0.017)。本研究首次证明了巴西里约热内卢感染HIV并发生淋巴瘤的儿童和青少年的生存情况和预后因素。